A 2015 analyze from the Journal of Weight problems & Metabolic Syndrome addresses common adverse activities and critical side effects of anti-weight problems prescription drugs, including phentermine/topiramate that will need monitoring, like metabolic acidosis, urolithiasis, acute angle closure